Doctors ‘highly positive’ on AbbVie’s Rinvoq in IBD, but not so much on Bristol Myers’ Zeposia: analyst

Doctors ‘highly positive’ on AbbVie’s Rinvoq in IBD, but not so much on Bristol Myers’ Zeposia: analyst
aliu
Mon, 02/22/2021 – 10:38